These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myocardial protection during elective coronary artery bypass grafting using high-dose insulin therapy. Albacker TB; Carvalho G; Schricker T; Lachapelle K Ann Thorac Surg; 2007 Dec; 84(6):1920-7; discussion 1920-7. PubMed ID: 18036907 [TBL] [Abstract][Full Text] [Related]
4. [The effects of insulin given prior to release of cross-clamp on coronary sinus lactate levels in coronary artery surgery]. Savaşkan D; Yurtseven N; Tuygun AK; Aksoy P; Canik S Anadolu Kardiyol Derg; 2006 Sep; 6(3):248-52. PubMed ID: 16943110 [TBL] [Abstract][Full Text] [Related]
5. Effects of high-dose glucose-insulin-potassium on myocardial metabolism after coronary surgery in patients with Type II diabetes. Szabó Z; Arnqvist H; Håkanson E; Jorfeldt L; Svedjeholm R Clin Sci (Lond); 2001 Jul; 101(1):37-43. PubMed ID: 11410112 [TBL] [Abstract][Full Text] [Related]
6. Effect of glucagon-like peptide-1 (GLP-1) on glycemic control and left ventricular function in patients undergoing coronary artery bypass grafting. Sokos GG; Bolukoglu H; German J; Hentosz T; Magovern GJ; Maher TD; Dean DA; Bailey SH; Marrone G; Benckart DH; Elahi D; Shannon RP Am J Cardiol; 2007 Sep; 100(5):824-9. PubMed ID: 17719327 [TBL] [Abstract][Full Text] [Related]
7. The effect of glutamate infusion on cardiac performance is independent of changes in metabolism in patients undergoing routine coronary artery bypass surgery. Langenberg CJ; Pietersen HG; Geskes G; Wagenmakers AJ; Lange SD; Schouten HJ; Soeters PB Clin Sci (Lond); 2001 Dec; 101(6):573-80. PubMed ID: 11724641 [TBL] [Abstract][Full Text] [Related]
8. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting. Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580 [TBL] [Abstract][Full Text] [Related]
9. Impact of mechanical and biological aortic valve replacement on coronary perfusion: a prospective, randomized study. Bakhtiary F; Abolmaali N; Dzemali O; Wittlinger T; Doss M; Moritz A; Kleine P J Heart Valve Dis; 2006 Jan; 15(1):5-11; discussion 11. PubMed ID: 16480006 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of esmolol as a myocardial protective agent during continuous retrograde blood cardioplegia. Scorsin M; Mebazaa A; Al Attar N; Medini B; Callebert J; Raffoul R; Ramadan R; Maillet JM; Ruffenach A; Simoneau F; Nataf P; Payen D; Lessana A J Thorac Cardiovasc Surg; 2003 May; 125(5):1022-9. PubMed ID: 12771874 [TBL] [Abstract][Full Text] [Related]
11. Diazoxide protects myocardial mitochondria, metabolism, and function during cardiac surgery: a double-blind randomized feasibility study of diazoxide-supplemented cardioplegia. Deja MA; Malinowski M; Gołba KS; Kajor M; Lebda-Wyborny T; Hudziak D; Domaradzki W; Szurlej D; Bończyk A; Biernat J; Woś S J Thorac Cardiovasc Surg; 2009 Apr; 137(4):997-1004, 1004e1-2. PubMed ID: 19327530 [TBL] [Abstract][Full Text] [Related]
12. High thoracic epidural analgesia decreases stress hyperglycemia and insulin need in cardiac surgery patients. Greisen J; Nielsen DV; Sloth E; Jakobsen CJ Acta Anaesthesiol Scand; 2013 Feb; 57(2):171-7. PubMed ID: 22762307 [TBL] [Abstract][Full Text] [Related]
13. Effects of cardiopulmonary bypass on glucose homeostasis after coronary artery bypass surgery. Anderson RE; Brismar K; Barr G; Ivert T Eur J Cardiothorac Surg; 2005 Sep; 28(3):425-30. PubMed ID: 16054822 [TBL] [Abstract][Full Text] [Related]
14. Does glutamate influence myocardial and peripheral tissue metabolism after aortic valve replacement for aortic stenosis? Vánky FB; Håkanson E; Jorfeldt L; Svedjeholm R Clin Nutr; 2006 Dec; 25(6):913-22. PubMed ID: 16737761 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery. Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264 [TBL] [Abstract][Full Text] [Related]
16. Intensive insulin therapy does not alter the inflammatory response in patients undergoing coronary artery bypass grafting: a randomized controlled trial [ISRCTN95608630]. Hoedemaekers CW; Pickkers P; Netea MG; van Deuren M; Van der Hoeven JG Crit Care; 2005; 9(6):R790-7. PubMed ID: 16356228 [TBL] [Abstract][Full Text] [Related]
17. Preconditioning with glucose-insulin-potassium solution and restoration of myocardial function during coronary surgery. Jovic M; Gradinac S; Lausevic-Vuk L; Nezic D; Stevanovic P; Milojevic P; Djukanovic B Gen Physiol Biophys; 2009; 28 Spec No():262-70. PubMed ID: 19893109 [TBL] [Abstract][Full Text] [Related]
18. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin. Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201 [TBL] [Abstract][Full Text] [Related]